746 search results
- Current search:
- Mental health
- Reset
Primary tabs
- Cochrane Evidence (active tab)
- Resources
- Handbooks & Manuals
- Training & Workshops
- News
- All Cochrane sites
-
NewCochrane EvidencePublished 5 Jul 2017
Vortioxetine for the treatment of depression in adults
Why is this review important? Many people suffer from major depression. Major depression is a serious illness that can cause significant distress both to patients and their families. Major depression affects people's work and relationships, but can also affect people physically, for example by changing concentration or appetite. Available antidepressant ... -
NewCochrane EvidencePublished 28 Jun 2017
Combining antipsychotic medication for the treatment of schizophrenia
Background Antipsychotic medication was introduced in the 1950s to reduce or alleviate the symptoms of schizophrenia, such as the psychotic states of hearing voices, visual hallucinations and strange thoughts such as paranoia (feeling singled-out or put upon by others). Medication for mental illness also helped to establish care in the community, ... -
NewCochrane EvidencePublished 28 Jun 2017
Wendan decoction for schizophrenia
Review question Is there trial-based evidence that a traditional Chinese herbal medicine, Wendan decoction (WDD) is effective for treatment of people with schizophrenia? Background Schizophrenia is a severe mental illness, characterised by profound disruptions in thinking that affects language, perception, and sense of self. People with schizophrenia ... -
NewCochrane EvidencePublished 17 Jun 2017
Magnetic seizure therapy for people with schizophrenia
Protocol: To estimate the effects of magnetic seizure therapy (MST) alone compared with sham MST or with standard care or any other comparators for schizophrenia. -
UpdatedCochrane EvidencePublished 15 Jun 2017
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia
Background Dementia is a global healthcare concern. Type 2 diabetes mellitus — a form of diabetes which becomes commoner with older age — increases the risk of developing dementia. Type 1 diabetes, which typically begins earlier in life, is always treated with insulin; but there are a variety of different ways of treating Type 2 diabetes, including ... -
NewCochrane EvidencePublished 14 Jun 2017
Clozapine dose in schizophrenia
Background: Schizophrenia is a severe mental illness that affects thinking and perception. People with schizophrenia often experience profound disruptions in their speech, emotional processes, behaviour and sense of self. Antipsychotic medication can be a helpful treatment for schizophrenia; however, taking antipsychotic medication can have unpleasant ... -
NewCochrane EvidencePublished 13 Jun 2017
Communication skills training for mental health professionals working with people with severe mental illness
Question Does communication skills training for mental health professionals benefit their patients with severe mental illness? Background Severe mental illness (such as schizophrenia or schizoaffective disorder) is a mental, behavioural or emotional disorder which severely interferes with, or limits a person’s life activities for a prolonged time ... -
NewCochrane EvidencePublished 11 Jun 2017
Assistive technology for memory support in dementia
Review question We wanted to find out from a review of the evidence whether Assistive Technology can help people with dementia overcome some of the effects of their memory problems. Background Dementia causes memory problems that make it increasingly difficult to carry out everyday activities, for example cooking, remembering appointments, taking ... -
Cochrane EvidencePublished 29 May 2017
Music therapy for schizophrenia or schizophrenia-like disorders
Review Question What are the effects of providing music therapy or adding music therapy to treatment for people with schizophrenia or schizophrenia-like disorders? Background Characteristics of schizophrenia and schizophrenia-like disorders are disordered thoughts, feelings, beliefs and perceptions. People with schizophrenia often have two main ... -
Cochrane EvidencePublished 23 May 2017
Interventions for treating anxiety after stroke
Review question To determine whether any treatments might reduce the symptoms of anxiety, and subsequently improve quality of life, for people who have had a stroke. Background Anxiety after stroke occurs frequently and can be treated with antidepressants or other anxiety-reducing drugs, or both, or with psychological therapy. Study characteristics Evidence ...
